June 3, 2015

Kidney Disease and Pulmonary Hypertension: A Deadly Duo

Study probes relationship between the two conditions

15-URL-072-Navaneethan-Hero-Image-690x380pxl

By Sankar Navaneethan, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Pulmonary hypertension (PH) is a progressive, fatal pulmonary circulatory disease that accompanies left or right ventricular failure.

Several factors lead to the development and worsening of PH, and kidney dysfunction and volume overload are common occurrences in clinical practice that can lead to increased pulmonary artery (PA) pressure. This decline in kidney function could be transiently related to hemodynamic changes during the treatment of volume overload associated with PH. These hemodynamic changes could lead to chronic kidney disease (CKD) if the insults are persistent or the underlying disease continues to worsen.

Examining CKD-PH Relationships

Since kidney disease in itself is a significant risk factor for death, it is relevant to examine its effects in the population with PH. Therefore, we attempted to determine if the presence of pre-existing non-dialysis-dependent CKD is an independent risk factor for death in patients with PH of varying etiology.

We studied 1,088 adult patients diagnosed with PH based on mean PA pressure > 25 mm Hg at rest as measured by right heart catheterization performed at our institution between 1996 and January 2011. The primary outcome of interest was all-cause mortality, which was ascertained from our electronic medical record and linkage of our data with the Social Security Death Index.

Patients were followed from their date of right heart catheterization until October 31, 2011. Mean age of the study cohort was 60 ± 15 years; 66 percent were females and 81 percent were white. Mean serum and estimated glomerular filtration rate (eGFR) was 72.2 ± 29 mL/min/1.73 m2. Mean PA pressure of the entire cohort was 47 ± 14 mm Hg. Among the 1,088 patients, 388 (36 percent) had evidence of CKD; 340 (31 percent) had stage 3 CKD and 48 (4 percent) had stage 4 CKD.

Advertisement

During the median follow-up period of 3.2 years (interquartile range 1.5 to 5.6 years), 559 (51 percent) of the total cohort died. Kaplan-Meier survival estimates at one year were 86 percent, 78 percent and 48 percent in those without CKD, with stage 3 CKD and with stage 4 CKD, respectively (log-rank p < 0.001; see Figure 1).

15-URL-072-Navaneethan-Inset-Image-02-590pxl-width

Figure 1. Survival based on eGFR in patients with pulmonary hypertension.

In the multivariable adjusted Cox proportional hazards model, the presence of eGFR < 60 mL/min/1.73 m2 was independently associated with mortality. When eGFR was examined as a continuous variable, every 5 mL/min/1.73 m2 decrease in eGFR was associated with a greater hazard for death (HR 1.05, 95% confidence interval [CI] 1.03-1.07). Presence of CKD did not seem to modify the associations between severity of PH and death.

Possible Explanations for CKD-PH-Associated Mortality

Pulmonary hypertension and CKD are disease states associated with poor outcomes. In this large cohort of patients with PH (based on right heart catheterization data), underlying CKD was highly prevalent. The observed association between CKD and mortality in our study could be explained by the higher prevalence of diastolic dysfunction and volume overload (resultant pulmonary congestion) in those with mild to moderate CKD.

In addition, other investigators have speculated on the potential influence of uremic toxins, bone mineral disorder and endothelial dysfunction on outcomes among those PH patients who are on dialysis. Particularly, these reports note that nitric oxide levels are reduced and release of nitric oxide is attenuated in patients on hemodialysis with PH. These deficiencies in nitric oxide often lead to increased pulmonary vascular tone, which in turn can promote arterial stiffness with resultant adverse consequences.

Advertisement

Whether such mechanistic pathways prevail in those with earlier stages of CKD, thereby causing higher mortality rates, is unknown and could be explored in CKD cohorts with longitudinal data relating to PH and left ventricular function. Our group is conducting these analyses, which might also help us identify novel risk stratification tools for our kidney disease patients.

Dr. Navaneethan is a staff member of Cleveland Clinic Glickman Urological & Kidney Institute’s Department of Nephrology and Hypertension.

Related Articles

heart showing obstructive cardiomyopathy
March 29, 2024
Mavacamten in the Real World: Study Demonstrates Safe Reduction in Eligibility for Septal Reduction Therapy

Logistic feasibility supported for treating obstructive HCM under the REMS program

mesh stent in a carotid artery
March 28, 2024
Carotid Revascularization Following the New CMS Coverage Decision: How to Operationalize Policies to Prioritize Outcomes

Insights from the Cleveland Clinic experience and a multispecialty alliance

tumor in an upper chamber of the heart
March 21, 2024
Excellent Outcomes Achievable With Surgical Resection of Benign Cardiac Tumors

Recurrences were rare and survival robust in large Cleveland Clinic study

illustration of the human heart focused on the left atrial appendage
March 12, 2024
Takeaways From Updated STS Guidelines for Surgical Treatment of Atrial Fibrillation

Concomitant AF ablation and LAA occlusion strongly endorsed during elective heart surgery

illustration of a figure-of-8 stitch for aortic valve repair
March 7, 2024
Figure-of-8, Hitch-Up Stitch Is Safe and Durable in Bicuspid Aortic Valve Repair

Large retrospective study supports its addition to BAV repair toolbox at expert centers

histology image of lung tissue showing spread through air spaces (STAS)
March 5, 2024
Lung Cancer Study Links Preoperative Factors With Spread Through Air Spaces

Young age, solid tumor, high uptake on PET and KRAS mutation signal risk, suggest need for lobectomy

x-ray of bone fracture in a forearm
March 1, 2024
TRAVERSE Substudy Links Testosterone Therapy to Increased Fracture Risk in Older Men With Hypogonadism

Surprise findings argue for caution about testosterone use in men at risk for fracture

echocardiogram showing severe aortic regurgitation
February 28, 2024
Early Referral for Enlarged Roots Critical to Prevent Residual AR After Aortic Root Replacement With Valve Reimplantation

Residual AR related to severe preoperative AR increases risk of progression, need for reoperation

Ad